GMCT Gynaecological Oncology Committee

A joint committee between the Cancer Institute NSW and the Greater Metropolitan Clinical Taskforce*

Co - Chair: Dr Chris Dalrymple

Senior gynaecological oncologist, Sydney Gynaecologic Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital

Dr Dalrymple is a senior gynaecological oncologist within the Sydney Gynaecologic Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital. His training was undertaken at Sydney University, Royal North Shore Hospital, Sydney, St Bartholomew’s Hospital London and the Regional Gynaecologic Oncology Unit, Gateshead, UK. He has been in practice within RPAH and privately for over 20 years in the areas of invasive and preinvasive gynaecological disease.

Previously he has been Chairman of the Australian Society of Gynaecological Oncology and remains upon its Executive, serves on the Committee of Management of the Australian Society for Colposcopy and Cervical Pathology, is a member of the NSW PTR Advisory Committee and of the RANZCOG Oncology Sub-Committee. He has served on the NSW GMTT/GMCT Gynaecologic Oncology Executive since 2004.

Co - Chair: Ms Kathryn Nattress

Cancer Nurse Coordinator, Sydney Cancer Centre, Royal Prince Alfred Hospital

Kathryn Nattress is a registered nurse who holds a bachelor's degree in science (nursing), a master's degree in medical science (palliative care), and a specialist practitioner qualification in palliative care. Kathryn has worked as a cancer nurse in Scotland and Australia for more than ten years and is Clinical Senior Lecturer at the University of Sydney in conjoint with her position as the cancer nurse coordinator for gynaecological cancer at the Sydney Cancer Centre. She has extensive experience in postgraduate education, policy development and research and is co-editor of "Gynaecological Cancer Care - A Guide to Practice"and a member of the editorial board of the Clinical Journal of Oncology Nursing. Kathryn has provided nursing representation on a variety of national working parties and has been involved in the development and implementation of guidelines for quality assurance, accreditation, and the management of ovarian cancer. Her research interests focus on the impact of disease and treatment in women with gynaecological cancer.

Key Activities of NSWOG Gynae-Oncology:

*Under the Greater Metropolitan Clinical Taskforce (GMCT), the Gynaecological Oncology Network has been operating since 2002. The GMCT Gynaecological Oncology Committee agreed to operate jointly as a NSW Oncology Group in 2006. For more information, please visit: http://www.health.nsw.gov.au/gmct